News & Events

  • November 14, 2018

    Nemaura Medical to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum

    LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible...

    November 12, 2018

    Nemaura Medical to Present at the Stifel 2018 Healthcare Conference

    LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible...

    November 8, 2018

    Nemaura Medical Inc. Reports Second Quarter 2018 Financial Results

    LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible...

    November 7, 2018

    Nemaura Successfully Develops Predictive Algorithms and Alarm Functionality for Continuous Glucose Monitor SugarBEAT®

    LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible...

    October 22, 2018

    Nemaura to Host Investor Webinar on October 23rd 2018 to Provide Update on Recent Developments

    LOUGHBOROUGH, England – Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible...

    September 25, 2018

    Nemaura Reports Positive Zero Finger-Stick Calibration Data for SugarBEAT® Continuous Glucose Monitor

    LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible...

    September 18, 2018

    Nemaura Signs Letter of Intent for SugarBEAT® Commercial Launch in Qatar

    LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible Continuous...

    September 12, 2018

    Nemaura Reports Positive Interim Data from Clinic Portion of SugarBEAT® FDA Clinical Trial

    LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible...

    August 28, 2018

    Nemaura Medical Strengthens Manufacturing Team in Preparation for SugarBEAT® Commercial Launch.

    LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive glucose trending device...

    August 9, 2018

    Nemaura Medical Inc. Reports First Quarter 2018 Financial Results

    LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive glucose trending device...